Roxadustat for Renal Anemia in ESRD from PKD Patients: Is It Safe Enough?

Affiliations

¹ Department of Nephrology, Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China.
² Department of Clinical Laboratory, Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China.
³ Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

Comment

Fei Liu et al. J Am Soc Nephrol. 2021 Apr.

. 2021 Apr;32(4):1005.

doi: 10.1681/ASN.2020111664. Epub 2021 Mar 1.

¹ Department of Nephrology, Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China.
² Department of Clinical Laboratory, Children's Hospital, National Clinical Research Center for Child Health, Zhejiang University School of Medicine, Hangzhou, China.
³ Children's Hospital, Zhejiang University School of Medicine, Hangzhou, China.

No abstract available

Keywords: anemia chronic kidney disease; polycystic kidney disease.

Comment on

Phase 3, Randomized, Double-Blind, Active-Comparator (Darbepoetin Alfa) Study of Oral Roxadustat in CKD Patients with Anemia on Hemodialysis in Japan.
Akizawa T, Iwasaki M, Yamaguchi Y, Majikawa Y, Reusch M. Akizawa T, et al. J Am Soc Nephrol. 2020 Jul;31(7):1628-1639. doi: 10.1681/ASN.2019060623. Epub 2020 Jun 3. J Am Soc Nephrol. 2020. PMID: 32493693 Free PMC article. Clinical Trial.
Authors' Reply.
Akizawa T, Iwasaki M, Yamaguchi Y, Majikawa Y, Reusch M. Akizawa T, et al. J Am Soc Nephrol. 2021 Apr;32(4):1005-1007. doi: 10.1681/ASN.2021010051. Epub 2021 Mar 1. J Am Soc Nephrol. 2021. PMID: 33649099 Free PMC article. No abstract available.

1. Akizawa T, Iwasaki M, Yamaguchi Y, Majikawa Y, Reusch M: Phase 3, randomized, double-blind, active-comparator (darbepoetin alfa) study of oral roxadustat in CKD patients with anemia on hemodialysis in Japan. J Am Soc Nephrol 31: 1628–1639, 2020 - PMC - PubMed
1. Akizawa T, Iwasaki M, Otsuka T, Reusch M, Misumi T: Roxadustat treatment of chronic kidney disease-associated anemia in Japanese patients not on dialysis: A phase 2, randomized, double-blind, placebo-controlled trial. Adv Ther 36: 1438–1454, 2019 - PMC - PubMed
1. Buchholz B, Eckardt K-U: Role of oxygen and the HIF-pathway in polycystic kidney disease. Cell Signal 69: 109524, 2020 - PubMed
1. Kraus A, Peters DJM, Klanke B, Weidemann A, Willam C, Schley G, et al. .: HIF-1α promotes cyst progression in a mouse model of autosomal dominant polycystic kidney disease. Kidney Int 94: 887–899, 2018 - PubMed